126 related articles for article (PubMed ID: 25739915)
1. A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression.
Vences-Catalán F; Kuo CC; Sagi Y; Chen H; Kela-Madar N; van Zelm MC; van Dongen JJ; Levy S
J Clin Immunol; 2015 Apr; 35(3):254-63. PubMed ID: 25739915
[TBL] [Abstract][Full Text] [Related]
2. Role of an arginine-lysine rich motif in maturation and trafficking of CD19.
Vences-Catalán F; Kuo CC; Levy S
Biochem Biophys Res Commun; 2015 Sep; 465(3):319-23. PubMed ID: 26111452
[TBL] [Abstract][Full Text] [Related]
3. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment.
Shoham T; Rajapaksa R; Boucheix C; Rubinstein E; Poe JC; Tedder TF; Levy S
J Immunol; 2003 Oct; 171(8):4062-72. PubMed ID: 14530327
[TBL] [Abstract][Full Text] [Related]
4. Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.
Shoham T; Rajapaksa R; Kuo CC; Haimovich J; Levy S
Mol Cell Biol; 2006 Feb; 26(4):1373-85. PubMed ID: 16449649
[TBL] [Abstract][Full Text] [Related]
5. A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking.
Susa KJ; Seegar TC; Blacklow SC; Kruse AC
Elife; 2020 Apr; 9():. PubMed ID: 32338599
[TBL] [Abstract][Full Text] [Related]
6. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.
van Zelm MC; Smet J; Adams B; Mascart F; Schandené L; Janssen F; Ferster A; Kuo CC; Levy S; van Dongen JJ; van der Burg M
J Clin Invest; 2010 Apr; 120(4):1265-74. PubMed ID: 20237408
[TBL] [Abstract][Full Text] [Related]
7. Function of the tetraspanin molecule CD81 in B and T cells.
Levy S
Immunol Res; 2014 May; 58(2-3):179-85. PubMed ID: 24522698
[TBL] [Abstract][Full Text] [Related]
8. Normal lymphocyte development but delayed humoral immune response in CD81-null mice.
Maecker HT; Levy S
J Exp Med; 1997 Apr; 185(8):1505-10. PubMed ID: 9126932
[TBL] [Abstract][Full Text] [Related]
9. The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes.
Vences-Catalán F; Rajapaksa R; Levy S; Santos-Argumedo L
Immunology; 2012 Sep; 137(1):48-55. PubMed ID: 22564057
[TBL] [Abstract][Full Text] [Related]
10. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.
Tsitsikov EN; Gutierrez-Ramos JC; Geha RS
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10844-9. PubMed ID: 9380722
[TBL] [Abstract][Full Text] [Related]
11. Cryo-EM structure of the B cell co-receptor CD19 bound to the tetraspanin CD81.
Susa KJ; Rawson S; Kruse AC; Blacklow SC
Science; 2021 Jan; 371(6526):300-305. PubMed ID: 33446559
[TBL] [Abstract][Full Text] [Related]
12. CD81 and CD19 as Marker of Activity in Systemic Lupus Erythematosus Disease.
Abu-Zahab Z; Gad NM; Sabry S; Nassib SA
Egypt J Immunol; 2017 Jun; 24(2):141-149. PubMed ID: 29528587
[TBL] [Abstract][Full Text] [Related]
13. Novel CD81 Mutations in a Chinese Patient Led to IgA Nephropathy and Impaired BCR Signaling.
Yang L; Liu P; Du H; Chen R; Zhou B; Li Y; Zhou L; Wang X; Liu C; Ding Y; Tang X; Chen Y; An Y; Zhao X
J Clin Immunol; 2022 Nov; 42(8):1672-1684. PubMed ID: 35849269
[TBL] [Abstract][Full Text] [Related]
14. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
[TBL] [Abstract][Full Text] [Related]
15. The signaling activity of murine CD19 is regulated during cell development.
Krop I; Shaffer AL; Fearon DT; Schlissel MS
J Immunol; 1996 Jul; 157(1):48-56. PubMed ID: 8683154
[TBL] [Abstract][Full Text] [Related]
16. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
17. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.
Zhu YZ; Luo Y; Cao MM; Liu Y; Liu XQ; Wang W; Wu DG; Guan M; Xu QQ; Ren H; Zhao P; Qi ZT
Virology; 2012 Aug; 429(2):112-23. PubMed ID: 22560863
[TBL] [Abstract][Full Text] [Related]
18. Deficiencies in the CD19 complex.
Wentink MWJ; van Zelm MC; van Dongen JJM; Warnatz K; van der Burg M
Clin Immunol; 2018 Oct; 195():82-87. PubMed ID: 30075290
[TBL] [Abstract][Full Text] [Related]
19. Open conformation of tetraspanins shapes interaction partner networks on cell membranes.
Yang Y; Liu XR; Greenberg ZJ; Zhou F; He P; Fan L; Liu S; Shen G; Egawa T; Gross ML; Schuettpelz LG; Li W
EMBO J; 2020 Sep; 39(18):e105246. PubMed ID: 32974937
[TBL] [Abstract][Full Text] [Related]
20. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
Ramanathan A; Gusarova V; Stahl N; Gurnett-Bander A; Kyratsous CA
PLoS One; 2016; 11(4):e0154498. PubMed ID: 27115873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
